Evidence map›Paper›PMID 27412028›Full record

ArticleUrolithiasis2017

Abnormal distal renal tubular acidification in patients with low bone mass: prevalence and impact of alkali treatment.

Jerzy Jan Sromicki, Bernhard Hess

Abstract read
PubMed Publisher
In one paragraph

Article in Urolithiasis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. UPDATE - Canadian Urological Association guideline: Evaluation and medical management of kidney stones.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2022
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Distal renal tubular acidosis: genetic causes and management.World journal of pediatrics : WJP · 2019
    Review
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Jerzy Jan SromickiInternal Medicine and Nephrology, Osteoporosis Center Zimmerberg, University of Zurich, Bellariastrasse 38, Klinik Im Park, 8038, Zurich, Switzerland.
Bernhard HessInternal Medicine and Nephrology, Osteoporosis Center Zimmerberg, University of Zurich, Bellariastrasse 38, Klinik Im Park, 8038, Zurich, Switzerland. bernhard.hess@hirslanden.ch.
Hirslanden Klinik Im Park · CHUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic acid retention is known to promote bone dissolution. In this study, 23 % of patients with osteopenia/osteoporosis were diagnosed with abnormal distal renal tubular acidification (dRTA), a kidney dysfunction leading to chronic acid retention. Treating those patients with alkali-therapy shows improvement in bone density. To evaluate the prevalence of abnormal distal renal tubular acidification in patients with low bone mass (LBM) and the impact of additional alkali treatment on bone density in patients with concomitant LBM and dRTA,183 patients referred for metabolic evaluation of densitometrically proven low bone mass were screened for abnormal distal renal tubular acidification between 2006 and 2013. In all LBM urine pH (U-pH) was measured in the 2nd morning urines after 12 h of fasting. If U-pH was ≥5.80, LBM underwent a 1-day ammonium chloride loading, and U-pH was remeasured the next morning. If U-pH after acid loading did not drop below 5.45, patients were diagnosed with abnormal distal renal tubular acidification. Normal values were obtained from 21 healthy controls. All LBM with dRTA were recommended alkali citrate in addition to conventional therapy of LBM, and follow-up DXAs were obtained until 2014. 85 LBM underwent NH

Indexed as

Acidosis, Renal TubularAdolescentAdultAgedAged, 80 and overAlkaliesAmmonium ChlorideBone DensityDensitometryFemaleFollow-Up StudiesHumansHydrogen-Ion ConcentrationKidney Tubules, DistalMaleMedication AdherenceAlkaliesAmmonium ChlorideAlkali treatmentBone dissolutionIncomplete renal tubular acidosisLow bone massMetabolic acidosis

Identifiers

PMID27412028
OpenAlexW2472001285

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.